Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients

Scandinavian Journal of Rheumatology

Volumn 40, Issue 5, 2011, Pages 341-346

  Targonska Stepniak B ^a   Majdan, M ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Department of Rheumatology and Connective Tissue Diseases ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AGENTS; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 80053419589     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.571219     Document Type: Article

References (34)

1. Karstila K, Korpela M, Sihvonen S, Mustonen J. Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol 2007;26:2089-95. (Pubitemid 350120347)
2. Koseki Y, Terai C, Moriguchi M, Uesato M, Kamatani N. A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:327-31. (Pubitemid 32242743)
3. Daoussis D, Panoulas VF, Antonopoulos I, John H, Toms TE, Wong P, et al. Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:517-21 .
4. Karie S, Gandjbakhch F, Janus N, Launay-Vacher V, Rozenberg S, Mai Ba CU, et al. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology 2008;47:350-4. (Pubitemid 351267205)
5. Braun A, Zeier M. Rheumatoid arthritis and the kidney: uneasy companions. Nephron Clin Pract 2005;96:c105-6.
6. Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A. Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 2004;96:c107-14. (Pubitemid 38581681)
7. Pixley J, Wolf B, O'Neill W. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab. Scand J Rheumatol 2008;37:313-14. (Pubitemid 351962327)
8. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-60. (Pubitemid 40664306)
9. Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem 2009;55:1932-43.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-70. (Pubitemid 29135798)
12. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 2007;22:1087-92. (Pubitemid 46523422)
13. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 2006;21:1855-62. (Pubitemid 43985713)
14. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman- Breen C, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006;145:237-46. (Pubitemid 46768607)
15. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007;115:173-9. (Pubitemid 46105715)
16. Emberson JR, Haynes R, Dasgupta T, Mafham M, Landray MJ, Baigent C, et al. Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men. J Intern Med 2010;268:145-54.
17. Sato H, Kuroda T, Tanabe N, Ajiro J, Wada Y, Murakami S, et al. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis. Scand J Rheumatol 2010;39:33-7.
18. Karstila K, Harmoinen AP, Lehtimaki TJ, Korpela MM, Mustonen JT, Saha HH. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance. Nephron Clin Pract 2008;108:c284-90. (Pubitemid 351704302)
19. Hayashi T, Ito S, Goto D, Matsumoto I, Sumida T. Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis. Mod Rheumatol 2010;20:548-55.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324. (Pubitemid 18091653)
21. Prevoo ML, Hof van MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that includes twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
22. Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol 2005; 32:1432-9. (Pubitemid 41113961)
23. Hoek FJ, Kemperman FAW, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003;18:2024-31. (Pubitemid 37220307)
24. Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens 2008;17:604-8.
25. Knight EL, Verhave JC, Spiegelman D, Hillege HL, Zeeuw DD, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-21. (Pubitemid 38406982)
26. Harmoinen A, Lehtimaki T, Korpela M, Turjanmaa V, Saha H. Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas. Clin Chem 2003;49:1223-5. (Pubitemid 36751123)
27. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njolstad I, et al. Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 2010; 78:1305-11.
28. Odden MC, Tager IB, Gansevoort RT, Bakker SJ, Katz R, Fried LF, et al. Age and cystatin C in healthy adults: a collaborative study. Nephrol Dial Transplant 2010;25:463-9.
29. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75:652-60.
30. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 2007; 71:239-44. (Pubitemid 46160924)
31. Keller C, Katz R, Sarnak MJ, Fried LF, Kestenbaum B, Cushman M, et al. Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant 2010;25:119-24.
32. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003;107:87-92. (Pubitemid 36070938)
33. Goeb V, Jouen F, Gilbert D, Le Loet X, Tron F, Vittecoq O. Diagnostic and prognostic usefulness of antibodies to citrullinated peptides. Joint Bone Spine 2009;76:343-9.
34. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001;47:2055-9. (Pubitemid 33010731)